Imeka has built a brain-imaging platform to quantify and understand brain connectivity, with a specific focus on “white matter.” Its platform combines diffusion imaging and deep learning to scan MRI images and map the brain structure. The venture aims to develop biomarkers to understand and develop cures for brain diseases.